These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024). Lentini S; Bossini A; Pirola LC Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124 [No Abstract] [Full Text] [Related]
5. Oral substitutes for insulin: modern appraisal of their action and indications. Isr J Med Sci; 1972 Jun; 8(6):677-710. PubMed ID: 4626310 [No Abstract] [Full Text] [Related]
6. [Clinical evaluation of Daonil--a new sulphonylurea derivative]. Nowotna-Walcowa R; Rozyńska E Pol Tyg Lek; 1971 Jan; 26(2):65-7. PubMed ID: 5101252 [No Abstract] [Full Text] [Related]
7. Oral sulphonylureas in the management of diabetes. Jackson WP S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995 [No Abstract] [Full Text] [Related]
8. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide. Iacono G; Ghionni A; Colucci M; Verde G; Caputo G Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166 [No Abstract] [Full Text] [Related]
13. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases. Emanueli A; Molari E; Pirola LC; Caputo G Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009 [No Abstract] [Full Text] [Related]
14. [Treatment of diabetes mellitus with hypoglycemic agents by oral route]. Confalonieri C Resen Clin Cient; 1970; 39(9):213-20. PubMed ID: 4921155 [No Abstract] [Full Text] [Related]
16. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus]. Ninni M; Castelletta L Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364 [No Abstract] [Full Text] [Related]
17. [Management of the side effects of oral hypoglycemic agents in diabetes mellitus]. Ishii J; Suzuki M Nihon Rinsho; 1990 Dec; 48 Suppl():955-61. PubMed ID: 2086978 [No Abstract] [Full Text] [Related]
18. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024. Parodi FA Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831 [No Abstract] [Full Text] [Related]
19. Clinical use of glibenclamide in diabetes mellitus. Luntz GR Postgrad Med J; 1970 Dec; ():Suppl:84-7. PubMed ID: 5533303 [No Abstract] [Full Text] [Related]